SCHEMBL8635047

SCHEMBL8635047

ON=C(c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.57
▸ GFER P55789 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ POLB P06746 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ XBP1 P17861 1/20 0.47
▸ KMT2A Q03164 4/20 0.46
▸ MGLL Q99685 1/20 0.45
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ PKM P14618 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ MEN1 O00255 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ PPARG P37231 1/20 0.42
▸ PPARA Q07869 1/20 0.42
▸ KCNK3 O14649 1/20 0.42
▸ KCNK9 Q9NPC2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11523488 0.91 ESR1 (0.50) HPGDGFERALDH1A1NPC1RAB9A
SCHEMBL28341134 0.88 HPGD (0.68) HPGDGFERALDH1A1POLBMAPT
SCHEMBL273196 0.85 HPGD (0.64) HPGDGFERALDH1A1POLBMAPT
SCHEMBL27961040 0.85 HPGD (0.64) HPGDGFERALDH1A1POLBMAPT
Water SCHEMBL9518556 0.83 HPGD (0.61) HPGDGFERALDH1A1POLBMAPT
SCHEMBL2009657 0.83 HPGD (0.48) HPGDGFERALDH1A1POLBMAPT
SCHEMBL2009658 0.83 HPGD (0.48) HPGDGFERALDH1A1POLBMAPT
SCHEMBL28739913 0.79 HPGD (0.59) HPGDGFERALDH1A1POLBMAPT
SCHEMBL17548937 0.79 ESR1 (0.59) HPGDGFERALDH1A1POLBMAPT
SCHEMBL8632122 0.79 ESR1 (0.59) HPGDGFERALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110606855-B Polysubstituted benzothienoisoquinoline, derivative and synthesis method thereof 湘潭大学 2022-03-18 — — CN claimed
CN-114394913-B Synthetic method of oxime ether derivative 山东农业大学 2023-02-03 — — CN disclosed
CN-114394913-A Synthetic method of oxime ether derivative 山东农业大学 2022-04-26 — — CN disclosed
US-5760025-A ADMINISTERING TESTOSTERONE 5A-REDUCTASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-06-02 — — US disclosed
US-5717088-A REACTING WITH A CYANOPHOSPHATE IN THE PRESENCE OF AN ALKALI METAL CYANIDE SANKYO COMPANY, LIMITED (JP) 1998-02-10 — — US disclosed
US-5698720-A INTERMEDIATES FOR TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-12-16 — — US disclosed
EP-0567271-B1 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses SANKYO CO (JP) 1997-07-02 — — EP disclosed
EP-0725074-A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives SANKYO COMPANY LIMITED (JP) 1996-08-07 — — EP disclosed
US-5536714-A Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses SANKYO COMPANY, LIMITED (JP) 1996-07-16 — — US disclosed
EP-0326516-B1 Method of making patterns CIBA GEIGY AG (CH) 1995-03-15 — — EP disclosed
EP-0567271-A2 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses SANKYO COMPANY LIMITED (JP) 1993-10-27 — — EP disclosed
US-4861438-A Method of making patterns CIBA-GEIGY CORPORATION (US) 1989-08-29 — — US disclosed
EP-0326516-A2 Method of making patterns CIBA-GEIGY AG (CH) 1989-08-02 — — EP disclosed
Send feedback